Alvarez & Marsal Announces 2025 Managing Director Promotions
16.1.2025 17:36:00 CET | Business Wire | Press release
Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 80 professionals, across Brazil, Canada, France, Germany, India, Italy, Spain, Sweden, United Arab Emirates, United Kingdom, and the United States, to the position of Managing Director.
Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “All of our newly promoted Managing Directors embody the talent and leadership necessary to deliver exceptional results that create value for A&M’s clients. Their contributions to the growth of our firm and the clients we serve cannot be understated. From around the world and across our many lines of service, they exemplify A&M’s unwavering commitment to integrity, quality and objectivity, and are essential to the firm’s continued success and expansion.”
- Russell Hunt, Houston
- Jack Kobus, Detroit
- Long Nguyen, Washington, D.C.
- Luis De Lencquesaing, New York
- Christopher Disa, New York
- Phani Mogalapu,Houston
Corporate Performance Improvement
- Kindra Bradshaw, Washington, D.C.
- Clark Caperton, Houston
- Rodrigo Carrillo, Houston
- Jeffrey Cass, Houston
- Trey Huffman, Atlanta
- Rob Koczo,Dallas
- Haley Leyendecker, Denver
- Andrew Monaco, Dallas
- Dan Phillips, Atlanta
- Brenden Phillips-Garrett, Los Angeles
- Eduardo Areilza, Madrid
- Massimo Franzese, London
- Tom Howitt, Abu Dhabi
- Hardeep Sandhu, London
- Florian Seehauser, Munich
- Jonas Strasdas, Munich
Private Equity Performance Improvement
- Colleen McCaughan, London
- Nick Mountfield, London
- Daniela Torresin, Milan
- Dario Bortot,London
- John Costoudes, Dubai
- Elizaveta Malashenko, Houston
Global Disputes and Investigations
- Jon Ahern, Denver
- Brad Koehler, New York
- John Bettley-Smith, London
- Daniella Divito,New York
- Emily Edwards, Atlanta
- Orion Ganase,London
- Alon Kritzman, New York
- Bruce Meyer, San Francisco
- Michael Noreman, Morristown
- Axel Ortjohann, Frankfurt
- Rob Piechota, Atlanta
- Chris Prout, London
Global Transaction Advisory Group
- Mike Baxter,Toronto
- Erminio Caporale, Chicago
- Kevin Cunha,San Francisco
- Ryan Donovan,Boston
- Vivian Leemans,Düsseldorf
- Kate Lowry,New York
- Ryan Macke, Chicago
- Callum Moore, Stockholm
- Gaurav Patel,Toronto
- Alex Rankin, Dubai
- Simon Regad,Paris
- Paul Spencer, London
- Michael Surr,New York
- Austin Wanland, Los Angeles
- Sujith Jain, Bangalore
Infrastructure & Capital Projects
- Felipe Bergson, Rio de Janeiro
- Bryan Müller, Belo Horizonte
- Alexandre Aguieiras, Rio de Janeiro
- Janice Garay, São Paulo
- Guilherme Kam, São Paulo
- Patrick Lopes, São Paulo
- Eduardo Teixeira, São Paulo
North American Commercial Restructuring
- Dwight Hingtgen,Chicago
- Landon Kenworthy,Dallas
- Paul Kinealy,Chicago
- Kumanan Ramanathan, New York
- Mauricio Rivera,San Francisco
- John Walsh,Houston
Private Equity Performance Improvement
- Alexander Galitsky,Chicago
- Vincent Juron,Charlotte
- Jason Kahn,Philadelphia
- Jeff Liddle, Houston
- Ahmed Suria,Philadelphia
- Ben Taylor,Atlanta
- Shiwali Tenner,Chicago
- Hameer Vaid,New York
- Christopher Baglio, Chicago
- Tracey Esposito, New York
- Roger Wilcock, London
About Alvarez & Marsal
Founded in 1983, Alvarez & Marsal is a leading global professional services firm. Renowned for its leadership, action and results, Alvarez & Marsal provides advisory, business performance improvement and turnaround management services, delivering practical solutions to address clients' unique challenges. With a world-wide network of experienced operators, world-class consultants, former regulators and industry authorities, Alvarez & Marsal helps corporates, boards, private equity firms, law firms and government agencies drive transformation, mitigate risk and unlock value at every stage of growth.
To learn more, visit: AlvarezandMarsal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250114027719/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom